RxDoctor Payments Data

Delora Brooks

Family · Saint Louis, MONPI 1659622330

Payments from drug & device makers

$2,782in general payments, 2019–2025

Across 176 payments — averaging $15.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$996
  • Lilly USA, LLC$325
  • AstraZeneca$196
  • Koya Medical, Inc.$161
  • Amgen$152
  • Otsuka America Pharmaceutical, Inc.$137
  • plus $816 from 19 others

What the payments were for

  • Food & beverage$2,782100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,782 in reported general payments places this provider in the 85th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide72$71,061
EliquisApixaban58$67,048
JardianceEmpagliflozin27$37,822
TrulicityDulaglutide19$21,493
JanuviaSitagliptin Phosphate13$19,853
EntrestoSacubitril/Valsartan11$11,610
Fluticasone-SalmeterolFluticasone Propion/Salmeterol63$11,580
LinzessLinaclotide11$11,151
Albuterol Sulfate HfaAlbuterol Sulfate320$8,731
SymbicortBudesonide/Formoterol Fumarate18$6,451
Gabapentin183$3,205
Lantus SolostarInsulin Glargine,hum.Rec.Anlog26$3,116
Wixela InhubFluticasone Propion/Salmeterol13$2,922
Epinephrine15$2,875
Diclofenac Sodium95$2,731

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$53$71,06172 claims
PfizerEliquis$93$67,04858 claims
Boehringer IngelheimJardiance$77$37,82227 claims
Lilly USA, LLCTrulicity$325$21,49319 claims
NovartisEntresto$34$11,61011 claims
AbbVieLinzess$996$11,15111 claims
AstraZenecaSymbicort$196$6,45118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,812 family providers in Missouri.

Other family in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →